Brain cell injection trial offers new hope for advanced Parkinson's patients
Disease control
Not yet recruiting
This early-stage study tests a single injection of special nerve cells (NouvNeu001) in 10 people with moderate-to-advanced Parkinson's who have already had deep brain stimulation or similar brain surgery. The main goal is to check if the injection is safe and tolerable. Researche…
Phase: PHASE1 • Sponsor: iRegene Therapeutics Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 06:30 UTC